Jove
Visualize
Contact Us

Related Concept Videos

Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

402
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
402
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.7K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.7K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

416
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
416
Schizophrenia01:17

Schizophrenia

626
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
626
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

733
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
733

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pragmatic Algorithm for Selecting Psychopharmacology Treatment for Secondary Insomnia.

Journal of clinical psychopharmacology·2026
Same author

Schizophrenia research in the post-COVID era: Emerging trends in 2026.

Current opinion in psychiatry·2026
Same author

Violent acts committed in the early phases of schizophrenia in the USA: risk factors, misconceptions, and implications for prevention.

Current opinion in psychiatry·2026
Same author

Biological insights into schizophrenia from ancestrally diverse populations.

Nature·2026
Same author

Preserving scientific discovery for future generations: a commentary.

Psychiatry research·2025
Same author

From 9/11/2001 to October 7, 2023 - The PreAct conference, NYC, June 2025: Preparing for mental health response to mass trauma.

Psychiatry research·2025
Same journal

Neuroimaging in older-age bipolar disorder.

Current opinion in psychiatry·2026
Same journal

Repetitive transcranial magnetic stimulation treatment for obsessive-compulsive disorder.

Current opinion in psychiatry·2026
Same journal

Pharmacological maintenance treatment in older age bipolar disorder.

Current opinion in psychiatry·2026
Same journal

Harmful behaviours and suicide in later life bipolar disorder.

Current opinion in psychiatry·2026
Same journal

Urbanization, wildfire exposure, and youth mental health: a narrative review.

Current opinion in psychiatry·2026
Same journal

Bipolar disorder and the risk of developing dementia - a systematic review and meta-analysis.

Current opinion in psychiatry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 28, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.4K

Opioid use and schizophrenia.

Kevin J Li1,2,3, Anderson Chen1,2,3, Lynn E DeLisi1,3,4

  • 1Department of Veterans Affairs (VA) Boston Healthcare System, Brockton Division.

Current Opinion in Psychiatry
|February 20, 2020
PubMed
Summary
This summary is machine-generated.

Schizophrenia and opioid use disorder (OUD) comorbidity is complex. Patients with both conditions receive suboptimal care and have poorer outcomes, highlighting the need for integrated treatment approaches.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.3K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.5K

Related Experiment Videos

Last Updated: Dec 28, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.4K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.3K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.5K

Area of Science:

  • Psychiatry
  • Neuroscience
  • Addiction Medicine

Background:

  • Schizophrenia and opioid use disorder (OUD) frequently co-occur.
  • OUD may increase the risk of developing schizophrenia, while schizophrenia patients with OUD face worse prognoses.

Purpose of the Study:

  • To review current literature on the comorbidity of schizophrenia and OUD.
  • To explore the relationship, shared pathophysiology, and treatment strategies for these conditions.

Main Methods:

  • Literature review of epidemiological, neurobiological, and clinical studies.
  • Analysis of treatment outcomes for comorbid patients.

Main Results:

  • Patients with comorbid schizophrenia and OUD have reduced access to standard care, including medication-assisted treatment (MAT).
  • OUD exacerbates schizophrenia progression and is associated with poorer clinical outcomes.
  • Kappa opioid receptor involvement may underlie the shared pathophysiology.

Conclusions:

  • Integrated, dual-diagnosis treatment is crucial for patients with schizophrenia and OUD.
  • Utilizing second-generation antipsychotics, long-acting injectables, and MAT is recommended.
  • Further research is needed to clarify epidemiology, neurobiology, genetics, and treatment.